Bionano Genomics (BNGO) Finished Goods (2017 - 2026)

Bionano Genomics has disclosed Finished Goods across 10 years of filings, most recently posting $1.9 million for Q1 2026.

• Finished Goods for Q1 2026 came in at $1.9 million, down 43.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 43.87% YoY), and the FY2025 annual result was $1.6 million, down 61.4% from the prior year.
• Finished Goods came in at $1.9 million for Q1 2026 at Bionano Genomics, up from $1.6 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $19.8 million in Q2 2022 to a low of $1.6 million in Q4 2025.
• The 5-year median for Finished Goods is $9.6 million (2024), against an average of $9.8 million.
• Across the five-year window, Finished Goods surged 4943.0% in 2022 and tumbled 78.53% in 2025, its largest moves.
• Bionano Genomics' Finished Goods stood at $17.4 million in 2022, then plunged by 41.08% to $10.2 million in 2023, then sank by 58.89% to $4.2 million in 2024, then slumped by 61.4% to $1.6 million in 2025, then rose by 14.02% to $1.9 million in 2026.
• The last three Finished Goods figures came in at $1.9 million (Q1 2026), $1.6 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.